Related Experiment Video

Updated: Jun 26, 2025

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.2K

Opioid vaccine clinical testing: lessons learned

Rachel Luba1,2, Sandra D Comer1,2

  • 1Department of Psychiatry, Columbia University Irving Medical Center.

Current Opinion in Psychiatry
|May 10, 2024
PubMed
Abstract

Insights

Developing opioid vaccines offers a novel approach to combat opioid use disorder (OUD). This review examines clinical trial design, practical considerations, and future directions for these promising OUD treatments.

Area of Science:

  • Pharmacology
  • Immunology
  • Clinical Trials

Background:

  • Opioid use disorder (OUD) is a critical public health issue with rising mortality.
  • Current treatments for OUD have limited engagement and retention rates.
  • Vaccines targeting opioids represent a novel therapeutic strategy.

Purpose of the Study:

  • To review existing literature on opioid vaccines.
  • To outline practical considerations for designing and conducting clinical trials for OUD vaccines.
  • To discuss future research directions in this field.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of clinical trial design elements, including endpoints and timing.
  • Examination of practical challenges and lessons learned from ongoing trials.

Main Results:

  • Vaccine development for OUD requires strong preclinical-to-clinical collaboration.
  • Learning from past clinical trial shortcomings is crucial for OUD vaccine design.
  • Balancing participant safety, retention, and data collection is key for trial success.

Conclusions:

  • Opioid vaccines hold promise as a complementary treatment for OUD.
  • Careful clinical trial design and implementation are essential for successful vaccine development.
  • Continued research and collaboration are needed to advance OUD vaccine therapies.

More Related Videos

Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord08:41

Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord

Published on: May 12, 2018

18.1K
In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D08:15

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

Published on: December 9, 2022

1.8K

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
584
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
239
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
283
Vaccinations01:51

Vaccinations

Overview
44.4K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K